LENZ Therapeutics, Inc.
Form 10-K and in subsequent filings Entrada may make with the SEC. In addition, the forward-looking statements included in this press ...
united states securities and exchange commission - Cloudfront.netThe Critical Accounting Policies and Significant Judgments and Estimates included in our Annual Report on Form 10-K for the year ended December ... Cabaletta Bio, Inc.entitled ?Risk Factors? in our most recent Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in our ... FORM 10-K - Annual ReportsI have reviewed this Annual Report on Form 10-K of Acrivon Therapeutics, Inc.;. 2. Based on my knowledge, this report does not contain any ...
Autres Cours:
